Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.57 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | F13A1 | P00488 | 3/20 | 0.52 |
| ▸ | CBS | P35520 | 2/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.50 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.50 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6353317 | 0.94 | HDAC3 (0.57) | MAPTRXFP1PTGS2CYP3A4F13A1 | |
| SCHEMBL490382 | 0.85 | KEAP1 (0.54) | MAPTPTGS2CYP3A4 | |
| Glutarate SCHEMBL17203217 | 0.82 | SLC22A6 (0.61) | F13A1HDAC3MAPK1ADRA1AHDAC4 | |
| SCHEMBL31672996 | 0.82 | MAPT (0.55) | MAPTRXFP1F13A1HDAC3MAPK1 | |
| SCHEMBL1049248 | 0.81 | HDAC6 (0.67) | MAPTRXFP1CBSHDAC3MAPK1 | |
| SCHEMBL30303107 | 0.81 | HDAC6 (0.67) | MAPTRXFP1CBSHDAC3MAPK1 | |
| SCHEMBL5493077 | 0.80 | HDAC6 (0.69) | MAPTRXFP1CBSHDAC3MAPK1 | |
| SCHEMBL7740301 | 0.80 | HDAC6 (0.69) | MAPTRXFP1CBSHDAC3MAPK1 | |
| SCHEMBL2516535 | 0.79 | ALB (0.59) | MAPTRXFP1PTGS2CYP3A4CBS | |
| Bisnorstriatol SCHEMBL9396838 | 0.79 | PTGS2 (0.77) | PTGS2CYP3A4CBSSLC6A3TBXAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1345 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144806-A1 | FORMULATION AND NONCOVALENT STABILIZATION OF OLIVETOLIC ACID DERIVATIVES | MINGOWOOD PHARMACAL LLC (US) | 2026-05-28 | — | — | US | claimed |
| US-20260115112-A1 | PARTICULATES OF POLYPHENOLICS AND DISPERSIONS THEREOF | SOLESENCE INC (US) | 2026-04-30 | — | — | US | claimed |
| US-12582663-B2 | Compositions comprising decarboxylated cannabinoids | Natural Extraction Systems, LLC (US) | 2026-03-24 | — | — | US | claimed |
| US-12540341-B2 | Biosynthetic platform for the production of olivetolic acid and analogues of olivetolic acid | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-02-03 | — | — | US | claimed |
| US-12540315-B2 | Compositions and methods for using genetically modified enzymes | RENEW BIOPHARMA, INC. (US) | 2026-02-03 | — | — | US | claimed |
| EP-4680720-A1 | OPTIMIZED PRODUCTION OF BRANCH POINT COMPOUNDS AND DERIVATIVES USING ALTERNATIVE ISOPENTENYL DIPHOSPHATE-SUPPLYING PATHWAYS | EvodiaBio ApS (DK) | 2026-01-21 | — | — | EP | claimed |
| US-12529077-B2 | Production of geranyl diphosphate-derived compounds | Københavns Universitet (DK) | 2026-01-20 | — | — | US | claimed |
| US-12480144-B2 | Cannabinoid synthase variants and methods for their use | CREO INGREDIENTS, INC. (US) | 2025-11-25 | — | — | US | claimed |
| US-20250346871-A1 | PRENYLTRANSFERASES AND METHODS OF MAKING AND USE THEREOF | CELLIBRE INC (US) | 2025-11-13 | — | — | US | claimed |
| US-12460185-B2 | Optimized cannabinoid synthase polypeptides | DEMETRIX, INC. (US) | 2025-11-04 | — | — | US | claimed |
| WO-2017161041-A1 | MICROBIAL SYNTHESIS OF ISOPRENOID PRECURSORS, ISOPRENOIDS AND DERIVATIVES INCLUDING PRENYLATED AROMATICS COMPOUNDS | WILLIAM MARSH RICE UNIVERSITY (US) | 2017-09-21 | — | — | WO | claimed |
| US-9765308-B2 | Aromatic prenyltransferase from cannabis | THE UNIVERSITY OF SASKATCHEWAN (CA) | 2017-09-19 | — | — | US | claimed |
| WO-2017139496-A1 | MICROBIAL ENGINEERING FOR THE PRODUCTION OF CANNABINOIDS AND CANNABINOID PRECURSORS | CEVOLVA BIOTECH, INC. (US) | 2017-08-17 | — | — | WO | claimed |
| US-20170233779-A1 | GENES AND PROTEINS FOR AROMATIC POLYKETIDE SYNTHESIS | UNIVERSITY OF SASKATCHEWAN (CA) | 2017-08-17 | — | — | US | claimed |
| WO-2017020043-A2 | BIOSYNTHESIS OF POLYKETIDES | WILLIAM MARSH RICE UNIVERSITY (US) | 2017-02-02 | — | — | WO | claimed |
| US-20150128301-A1 | AROMATIC PRENYLTRANSFERASE FROM CANNABIS | UNIVERSITY OF SASKATCHEWAN (CA) | 2015-05-07 | — | — | US | claimed |
| US-20130067619-A1 | GENES AND PROTEINS FOR AROMATIC POLYKETIDE SYNTHESIS | UNIVERSITY OF SASKATCHEWAN (CA) | 2013-03-14 | — | — | US | claimed |
| WO-2011127589-A1 | GENES AND PROTEINS FOR AROMATIC POLYKETIDE SYNTHESIS | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2011-10-20 | — | — | WO | claimed |
| US-7196214-B2 | Process for arylamine production | XEROX CORPORATION (US) | 2007-03-27 | — | — | US | claimed |
| US-20060111582-A1 | Process for arylamine production | XEROX CORPORATION (US) | 2006-05-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12529077-B2 | Production of geranyl diphosphate-derived compounds | GGPS1, OGA, GBA3 | MAPT 2898/4885RXFP1 4203/4885PTGS2 1532/4885 |
| US-12540341-B2 | Biosynthetic platform for the production of olivetolic acid and analogues of olivetolic acid | COASY, HPD, FADS2 | MAPT 3070/4885RXFP1 2117/4885PTGS2 2498/4885 |
| US-12540315-B2 | Compositions and methods for using genetically modified enzymes | COASY, CYP4F3, CYP4F11 | MAPT 3590/4885RXFP1 3736/4885PTGS2 2841/4885 |
| US-20260144806-A1 | FORMULATION AND NONCOVALENT STABILIZATION OF OLIVETOLIC ACID DERIVATIVES | LDHA, LDHB, FAAH | MAPT 962/4885RXFP1 4706/4885PTGS2 147/4885 |
| US-20260115112-A1 | PARTICULATES OF POLYPHENOLICS AND DISPERSIONS THEREOF | CUTA, HAAO, PPARG | MAPT 1547/4885RXFP1 2567/4885PTGS2 3818/4885 |
| US-20060111582-A1 | Process for arylamine production | AOC2, UFM1, TYR | MAPT 1696/4885RXFP1 4005/4885PTGS2 4018/4885 |
| US-12582663-B2 | Compositions comprising decarboxylated cannabinoids | GGPS1, PGGT1B, CNR2 | MAPT 583/4885RXFP1 4518/4885PTGS2 1701/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.